Effects of Proanthocyanidins on Arsenic Methylation Metabolism and Efflux in Human Hepatocytes L-02

<table class="fixed-width table-group" id="tab1"><tr><td><table class="table"><colgroup><col style="width:9.73em"/><col style="width:15.12em"/></colgroup><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Group</td><td class="align_center">Treatment measures</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Blank control group</td><td class="align_center">As<sub>2</sub>O<sub>3</sub> + PC (0<i>μ</i>mol/L + 0mg/L)</td></tr><tr><td class="align_left">ATO exposure group</td><td class="align_center">As<sub>2</sub>O<sub>3</sub> + PC (25<i>μ</i>mol/L + 0mg/L)</td></tr><tr><td class="align_left">PC-treated group</td><td class="align_center">As<sub>2</sub>O<sub>3</sub> + PC (25<i>μ</i>mol/L + 10mg/L)</td></tr><tr><td class="align_left">PC-treated group</td><td class="align_center">As<sub>2</sub>O<sub>3</sub> + PC (25<i>μ</i>mol/L + 25mg/L)</td></tr><tr><td class="align_left">PC-treated group</td><td class="align_center">As<sub>2</sub>O<sub>3</sub> + PC (25<i>μ</i>mol/L + 50mg/L)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>Note: PC, proanthocyanidins; ATO, arsenic trioxide.<br/></div></td></tr></table>

<div>Treatment measures and grouping.</div>

BioMed Research International

tab1

Table 1

Table 1: Effects of Proanthocyanidins on Arsenic Methylation Metabolism and Efflux in Human Hepatocytes L-02 